Found 13 matching trials
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study PHASE2 This study is testing a new medicine called AK112 (Yivoximab) for people wi...
Show More Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
RegoNivo vs Standard of Care Chemotherapy in AGOC PHASE3 To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations PHASE2 This study was a single-arm, open-label, phase II study of PD-1 monoclonal ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer PHASE1 This first-in-human (FIH) study for BNT116 aims to establish the safety pro...
Show More Location
University of Kentucky Chandler Medical Center
Learn More & Join Trial
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC) PHASE2 This is a multi-center,open-label study to evaluate the efficacy and safety...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer PHASE2 The efficacy of combining TKI with PD-1 inhibitor in the treatment of advan...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study PHASE2 The goal of this clinical trial is to learn whether a high- and low-dose ra...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of transar...
Show More Learn More & Join Trial
Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma NA The aim of this study is to compare the efficacy and safety of transcathete...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial